| scholarly article | Q13442814 |
| P2093 | author name string | Gillberg C | |
| Svennerholm L | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Other pervasive developmental disorders | Q51718774 |
| autism | Q38404 | ||
| P304 | page(s) | 89-94 | |
| P577 | publication date | 1987-07-01 | |
| P1433 | published in | British Journal of Psychiatry | Q4035428 |
| P1476 | title | CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood | |
| P478 | volume | 151 |
| Q50312788 | A neurobehavioral examination of individuals with high-functioning autism and Asperger's disorder using a fronto-striatal model of dysfunction |
| Q40594084 | Adaptation and habituation to an open field and responses to various stressful events in animals with neonatal lesions in the amygdala or ventral hippocampus |
| Q22241891 | Antipsychotics in the treatment of autism |
| Q34238174 | Are There any Relationships between Latent Toxoplasma gondii Infection, Testosterone Elevation, and Risk of Autism Spectrum Disorder? |
| Q35146733 | Association of ADHD, tics, and anxiety with dopamine transporter (DAT1) genotype in autism spectrum disorder |
| Q37497115 | Association of social and cognitive impairment and biomarkers in autism spectrum disorders |
| Q30607088 | Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy |
| Q44914300 | CSF beta-endorphins in childhood neuropsychiatric disorders |
| Q42278156 | Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism |
| Q40831232 | Cerebrospinal fluid monoamines in Prader-Willi syndrome |
| Q88998395 | Childhood autism: An appeal for an integrative and psychobiological approach |
| Q48432360 | Childhood autism: the need for physical investigations |
| Q36342328 | DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families |
| Q41127544 | Development in the metabolism of dopamine and its derivatives. Application to gross development disorders |
| Q37523280 | Diagnostic and assessment issues related to pharmacotherapy for children and adolescents with autism |
| Q34073325 | Emerging drugs for the treatment of symptoms associated with autism spectrum disorders |
| Q37706525 | Epidemiology and management of insomnia in children with autistic spectrum disorders |
| Q50302202 | Gender identity disorder in a girl with autism--a case report |
| Q35991106 | Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study. |
| Q88998310 | Girls with social deficits and learning problems: Autism, atypical Asperger syndrome or a variant of these conditions |
| Q50302638 | Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation |
| Q36025654 | Individual differences in vulnerability for self-injurious behavior: studies using an animal model |
| Q40819750 | Intelligence patterns among children with high-functioning autism, phenylketonuria, and childhood head injury |
| Q88998419 | Investigation of whole blood and urine monoamines in autism |
| Q30623213 | Medication treatment in subjects with autistic spectrum disorders |
| Q24602037 | Monoamine oxidase A and A/B knockout mice display autistic-like features |
| Q22248039 | Neurobiological Correlates of Autism: A Review of Recent Research |
| Q50309956 | Pathophysiology of autism: current opinions |
| Q89823252 | Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain-Part II |
| Q43907643 | Plasma and urinary levels of biopterin, neopterin, and related pterins and plasma levels of folate in infantile autism |
| Q33664787 | Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders |
| Q50227781 | RIT2 Polymorphisms: Is There a Differential Association? |
| Q37661363 | Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala |
| Q38089714 | Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy |
| Q33992113 | The Emanuel Miller Memorial Lecture 1991. Autism and autistic-like conditions: subclasses among disorders of empathy |
| Q50303371 | The psychopharmacology of autism and related disorders |
| Q50766340 | Use of drawings in children with pervasive developmental disorder during hospitalization: a developmental perspective. |
Search more.